Eric Okerberg

Title: **Innovative Contributions of Eric Okerberg in Biotech**

Introduction

Eric Okerberg, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of biotechnology. With a strong focus on high-throughput serotyping and conjugation methods, his innovative work has led to the granting of two patents. His expertise and inventions are pivotal in advancing medical diagnostics and therapeutic development.

Latest Patents

Eric Okerberg's latest patents reflect his commitment to enhancing technological capabilities in serotyping and antibody profiling. One of his notable patents is the **High-throughput serotyping and antibody profiling assays**. This groundbreaking invention provides high-throughput, population-wide serotyping that utilizes next-generation sequencing to measure the serotyping profile of barcoded subject serum antibodies. The assay setup enables multiplexing, generating extensive serotyping data that can track various pathogens and adapt to the ever-evolving landscape of infectious diseases. Additionally, it holds promise for applications in cancer immunology, autoimmune conditions, and biosecurity.

Another significant patent involves **Conjugation reagents and methods using 1,2-cyclohexanediones**. This invention outlines methods for attaching labels and other molecules to target compounds via cyclohexan-1,2-dione groups. The methods facilitate reactions under milder conditions, making them compatible with base-sensitive compounds and complex biomolecules. This technique is particularly beneficial for linking labeling groups to peptides and nucleic acids, thereby expanding its application in various areas of biotechnology.

Career Highlights

Eric Okerberg currently works at Encodia, Inc., where he continues to drive innovation in the biotech sector. His extensive knowledge and inventive contributions have placed him at the forefront of technological advancements, impacting both academic research and clinical practices.

Collaborations

Throughout his career, Eric has collaborated with esteemed colleagues, including Kevin L. Gunderson and Norihito Muranaka. Their combined expertise and teamwork contribute to the development of cutting-edge technologies that enhance research capabilities and therapeutic approaches.

Conclusion

Eric Okerberg stands out as a notable inventor whose contributions to biotechnology are paving the way for future innovations. His patents not only improve current methodologies but also open new avenues for research and development in medical diagnostics and treatment. As he continues his work at Encodia, Inc., the impact of his inventions will undoubtedly resonate within the scientific community and beyond.